Table 3 Serum Ca control with repeated administrations of BP
From: Administration of bisphosphonate for hypercalcemia associated with oral cancer
|  | mean ± s.d. | median | min. ~max. |
|---|---|---|---|
1st administration (n = 9) | |||
pre Ca (mg/dl) | 13.4 ± 1.2 | 12.9 | 12.2 ~16.0 |
post lowest Ca (mg/dl) | 10.7 ± 0.8 | 10.6 | 9.6 ~12.2 |
Ca decrease (mg/dl) | 2.7 ± 1.5 | 2.2 | 1.6 ~6.1 |
2nd administration (n = 6) | |||
pre Ca (mg/dl) | 13.0 ± 1.2 | 12.5 | 11.8 ~14.5 |
post lowest Ca (mg/dl) | 11.4 ± 0.9 | 11.2 | 10.5 ~13.0 |
Ca decrease (mg/dl) | 1.6 ± 0.7 | 1.5 | 0.7 ~2.7 |
3rd administration (n = 4) | |||
pre Ca (mg/dl) | 13.3 ± 1.1 | 13.1 | 11.8 ~14.7 |
post lowest Ca (mg/dl) | 12.8 ± 2.3 | 11.8 | 10.7 ~16.0 |
Ca decrease (mg/dl) | 0.5 ± 1.5 | 0.7 | -1.9 ~2.2 |